End-of-life care from the perspective of primary care providers.

Journal of General Internal Medicine
Maria J Silveira, Jane Forman

Abstract

To explore the factors influencing primary care providers' ability to care for their dying patients in Michigan. We conducted 16 focus groups to explore the provision of end-of-life care by 7 diverse primary care practices in southeast Michigan. Twenty-eight primary care providers and 22 clinical support staff participated in the study. Interviews were analyzed using thematic analysis. Primary care providers (PCPs) wanted to care for their dying patients and felt largely competent to provide end-of-life care. They and their staff reported the presence of five structural factors that influenced their ability to do so: (1) continuity of care to help patients make treatment decisions and plan for the end of life; (2) scheduling flexibility and time with patients to address emergent needs, provide emotional support, and conduct meaningful end-of-life discussions; (3) information-sharing with outside providers and within the primary care practice; (4) coordination of care to address patients' needs quickly; and (5) authority to act on behalf of their patients. In order to provide end-of-life care, PCPs need structural supports within primary care for continuity of care, flexible scheduling, information-sharing, coordination of prima...Continue Reading

References

Sep 1, 1990·BMJ : British Medical Journal·J TownsendM Piper
Nov 15, 1997·Journal of the American Geriatrics Society·L C HansonJ Garrett
Sep 12, 1998·Annals of Internal Medicine·J A TulskyR M Arnold
May 12, 2000·Archives of Pediatrics & Adolescent Medicine·C B ForrestB Starfield
Oct 13, 2000·Journal of General Internal Medicine·T K GandhiD W Bates
Nov 14, 2000·JAMA : the Journal of the American Medical Association·K E SteinhauserJ A Tulsky
Jan 16, 2002·The American Journal of Medicine·B Lo
Apr 16, 2002·Academic Medicine : Journal of the Association of American Medical Colleges·Elizabeth H BradleySarah M Horwitz
Aug 2, 2003·Qualitative Health Research·Margarete Sandelowski, Julie Barroso
Jan 8, 2004·JAMA : the Journal of the American Medical Association·Joan M TenoVincent Mor
Jan 22, 2004·Journal of Palliative Medicine·Frederick BurgeIna Cummings
Apr 7, 2005·Palliative Medicine·Marieke M GrootRichard P T M Grol
Aug 17, 2005·International Journal of Nursing Studies·Fiona AspinalJulia Addington-Hall
Apr 14, 2007·Journal of General Internal Medicine·Hector P RodriguezDana Gelb Safran
Aug 29, 2009·American Journal of Respiratory and Critical Care Medicine·Hannah WunschDerek C Angus
Apr 14, 2010·Journal of the National Cancer Institute. Monographs·Paul K J Han, Daniel Rayson
Sep 17, 2010·Annals of Family Medicine·Carolyn TarrantTim Stokes
Feb 8, 2011·Anesthesiology Clinics·Rebecca Aslakson, Peter J Pronovost
Nov 30, 2012·Journal of General Internal Medicine·Gala TrueRachel M Werner

❮ Previous
Next ❯

Citations

Oct 3, 2015·The American Journal of Hospice & Palliative Care·Lisa C Lindley, Savithri Nageswaran
Dec 5, 2018·Southern Medical Journal·Marjorie A BowmanAdrienne Stolfi
Mar 7, 2020·Journal of Palliative Care·Lauren K Hall, Randy Hebert
Jul 25, 2021·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Danielle B AmundsenLarissa Nekhlyudov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.